P&T
Our
Other
Journal
MediMedia Managed Markets

 

Who Will Pay for High-Cost Biologics?

Who Will Pay for High-Cost Biologics?

Insurance coverage was never meant to handle new pharmaceutical breakthroughs on the radar — breakthroughs that can cost anywhere from $90,000 to $300,000 a year per patient, says F. Randy Vogenberg, RPh, PhD, principal of the Institute for Integrated Healthcare and a member of P&T’s Editorial Board. There will be pressure on everybody to find a way to somehow control these costs.